Aspen Pharmacare Holdings Ltd

Common Name
Aspen Pharmacare Holdings
Country
South Africa
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
9,128
Ticker
APN
Exchange
JOHANNESBURG STOCK EXCHANGE
Description
Aspen Pharmacare Holdings Limited is a leading global pharmaceutical company with a strong presence in the healthcare sector. Founded in South Africa, the company is involved in manufacturing, distrib...

Aspen Pharmacare Holdings's GHG Emissions Data Preview

In 2025, Aspen Pharmacare Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Aspen Pharmacare Holdings has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2025202420232022 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind Aspen Pharmacare Holdings’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Aspen Pharmacare Holdings’s data sources below and access millions more through our Disclosure Search.

a. Aspen Pharmacare Holdings's ESG Data Spreadsheet 2025
a. Aspen Pharmacare Holdings's ESG Data Spreadsheet 2025
b. Aspen Pharmacare Holdings's Integrated Report 2023
b. Aspen Pharmacare Holdings's Integrated Report 2023

Insights into Aspen Pharmacare Holdings's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Aspen Pharmacare Holdings amounted to 148,281 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Aspen Pharmacare Holdings increased by 5.18%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Aspen Pharmacare Holdings's Scope 1 Emissions Over Time

2019202020212022202320242025015 k30 k45 k60 ktCO2e-10%+3%-10%-7%-13%+1%
  • Total Scope 1
  • Year-over-Year Change

What are Aspen Pharmacare Holdings's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Aspen Pharmacare Holdings were 32,776 metric tons of CO₂ equivalent (tCO₂e). a

Has Aspen Pharmacare Holdings reduced its Scope 1 emissions over time?

Since 2019, Aspen Pharmacare Holdings's Scope 1 emissions have decreased by 31.85%, reflecting a declining long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2024), Aspen Pharmacare Holdings's Scope 1 emissions remained relatively stable, indicating that Aspen Pharmacare Holdings's emissions have plateaued with no significant change in its operational footprint. a

What are Aspen Pharmacare Holdings's Scope 2 emissions?

In 2025, Aspen Pharmacare Holdings reported Scope 2 greenhouse gas (GHG) emissions of 115,505 tCO₂e without specifying the calculation method. a

Has Aspen Pharmacare Holdings reduced its Scope 2 emissions over time?

Since 2019, Aspen Pharmacare Holdings's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have decreased by 27.31%, reflecting a declining long-term trend in Scope 2 emissions over time. a b

Compared to the previous year (2024), Aspen Pharmacare Holdings's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Aspen Pharmacare Holdings 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does Aspen Pharmacare Holdings use for Scope 2 reporting?

In 2025, Aspen Pharmacare Holdings reported its Scope 2 emissions using an unspecified methodology. a

Aspen Pharmacare Holdings's Scope 2 Emissions Over Time

2019202020212022202320242025040 k80 k120 k160 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Aspen Pharmacare Holdings’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Aspen Pharmacare Holdings reported Scope 1 greenhouse gas (GHG) emissions of 32,776 tCO₂e and total revenues of USD 2,450 millions. This translates into an emissions intensity of 13.38 tCO₂e per millions USD. a

Aspen Pharmacare Holdings's Scope 1 Emissions Intensity Compared to Peers

2002,00010,000100,000500,000Scope 1 Emissions (tCO2e)2005001,0005,00010,000Revenues (Millions of USD)CCCNDSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MCCCR Double-CraneYear: 2023Scope 1: 51,608 tCO2eRevenue: $M 1,438Scope 1 Intensity: 35.88 tCO2e/$MAlmirallYear: 2023Scope 1: 6,318 tCO2eRevenue: $M 990Scope 1 Intensity: 6.38 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MHisamitsu PharmaceuticalYear: 2022Scope 1: 7,862 tCO2eRevenue: $M 1,040Scope 1 Intensity: 7.56 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MSawai Group HoldingsYear: 2023Scope 1: 19,500 tCO2eRevenue: $M 1,229Scope 1 Intensity: 15.87 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MSiegfried HoldingYear: 2024Scope 1: 59,171 tCO2eRevenue: $M 1,430Scope 1 Intensity: 41.39 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,830Scope 1 Intensity: 7.19 tCO2e/$MMankind PharmaYear: 2025Scope 1: 6,538 tCO2eRevenue: $M 1,429Scope 1 Intensity: 4.58 tCO2e/$MFagronYear: 2023Scope 1: 4,218 tCO2eRevenue: $M 844Scope 1 Intensity: 4.99 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MLaboratorios Farmaceuticos ROVIYear: 2024Scope 1: 9,566 tCO2eRevenue: $M 795Scope 1 Intensity: 12.04 tCO2e/$MYuhanYear: 2024Scope 1: 7,059 tCO2eRevenue: $M 1,409Scope 1 Intensity: 5.01 tCO2e/$MEvotecYear: 2024Scope 1: 13,756 tCO2eRevenue: $M 829Scope 1 Intensity: 16.59 tCO2e/$MGedeon RichterYear: 2024Scope 1: 45,632 tCO2eRevenue: $M 2,171Scope 1 Intensity: 21.02 tCO2e/$MCCChina TCMYear: 2024Scope 1: 104,425 tCO2eRevenue: $M 2,474Scope 1 Intensity: 42.21 tCO2e/$MTsumura & CoYear: 2021Scope 1: 39,385 tCO2eRevenue: $M 1,055Scope 1 Intensity: 37.32 tCO2e/$MGenomma Lab InternacionalYear: 2023Scope 1: 3,174 tCO2eRevenue: $M 971Scope 1 Intensity: 3.27 tCO2e/$MNNNippon ShinyakuYear: 2023Scope 1: 4,366 tCO2eRevenue: $M 1,082Scope 1 Intensity: 4.03 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MSumitomo PharmaYear: 2023Scope 1: 27,093 tCO2eRevenue: $M 4,171Scope 1 Intensity: 6.50 tCO2e/$MAspen Pharmacare HoldingsYear: 2025Scope 1: 32,776 tCO2eRevenue: $M 2,450Scope 1 Intensity: 13.38 tCO2e/$M

How does Aspen Pharmacare Holdings's GHG emissions intensity compare to its peers?

In 2025, Aspen Pharmacare Holdings reported a Scope 1 emissions intensity of 13.38 tCO₂e per millions USD. Compared to the peer group median of 9.47 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does Aspen Pharmacare Holdings rank on GHG emissions intensity within its industry?

In 2025, Aspen Pharmacare Holdings ranked 15 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Aspen Pharmacare Holdings is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Aspen Pharmacare Holdings's GHG Emissions Dataset?
Sign Up